Latest Lipitor Stories

No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.Robert Dellavalle, M.D., of Denver Veterans Affairs Medical Center and colleagues found no significant difference in melanoma rates between people taking statin or fibrate medication for high cholesterol and those who did not take either class of drug. The reviewers looked at 16 high-quality studies...

CHICAGO (Reuters) - Pfizer Inc. said on Tuesday U.S. regulators have approved its blockbuster cholesterol drug Lipitor to reduce the risk of stroke and heart attack in diabetic patients. Pfizer said the approval is for patients with type 2, or adult onset, diabetes who have no signs of heart disease but with other risk factors for the condition. Pfizer said Lipitor also received approval to reduce the risk of stroke in people without evidence of heart disease but with multiple risk...

By Carey Gillam KANSAS CITY, Missouri (Reuters) - A federal grand jury on Wednesday indicted three Midwestern businesses and 11 individuals in a conspiracy to sell illegal counterfeit drugs, including Lipitor, Pfizer's popular cholesterol-lowering medicine. "Today's indictment has significant national public health ramifications," U.S. Attorney Todd Graves said in a statement. "Tens of millions of dollars in counterfeit, illegally imported and stolen drugs were bought and sold and,...

LONDON -- First it was fake CDs, jeans and Rolex watches. Now organized criminals are turning to counterfeit medicines as the latest money-spinner, with potentially lethal results.Around the world, health authorities are battling a growing trade in fake medicines, which the World Health Organization (WHO) estimates is worth more than $30 billion a year.The problem is acute in parts of Asia and Africa, where fake drugs are rife, but rich countries are not immune.Just last week, British...

Dec. 1--It's common knowledge that high cholesterol increases the risks of heart attack. But having too little of a certain type of cholesterol can be hazardous as well, and currently there isn't much doctors can do, except urge their patients to lose weight and exercise. On Tuesday, Pfizer Inc., the world's largest drugmaker, outlined its plans to change that by combining its best-selling Lipitor cholesterol-lowering drug with another drug that boosts the "good" type of cholesterol....